Associated Papers
Genetic Therapy of Fuchs Endothelial Corneal Dystrophy: Where Are We? A Review.
Stunf Pukl S
Genes, 2025
From Genes to Disease: Reassessing LOXHD1 and AGBL1's Contribution to Fuchs' Dystrophy.
Tsedilina TR et al.
International Journal of Molecular Sciences, 2025
Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy.
Liu X et al.
Eye and Vision (london, England), 2021
Diseases of the corneal endothelium.
Jeang LJ et al.
Experimental Eye Research, 2021
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.
Ong Tone S et al.
Progress in Retinal and Eye Research, 2021
Mutations of uncertain significance in heterozygous variants as a possible cause of severe short stature: a case report.
Mohammadian Khonsari N et al.
Molecular and Cellular Pediatrics, 2020
The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.
Zhang J et al.
Molecular Diagnosis & Therapy, 2019
REVIEW: Current understanding of the pathogenesis of Fuchs' endothelial corneal dystrophy.
Nanda GG et al.
Molecular Vision, 2019
CTG18.1 Expansion is the Best Classifier of Late-Onset Fuchs' Corneal Dystrophy Among 10 Biomarkers in a Cohort From the European Part of Russia.
Skorodumova LO et al.
Investigative Ophthalmology & Visual Science, 2018
Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4.
Riazuddin SA et al.
American Journal of Human Genetics, 2013
Select a paper to view details